Healthcare entity
Every one of those 1 sits in a single category, regulation. Office of Prescription Drug Promotion (OPDP) is most often covered alongside American Medical Association (AMA), which appears in 1 of these 1 story. The 5 average consequence score is below the beat benchmark of 6 in the same window.
Last mentioned: Mar 9, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, regulation. Office of Prescription Drug Promotion (OPDP) is most often covered alongside American Medical Association (AMA), which appears in 1 of these 1 story. The 5 average consequence score is below the beat benchmark of 6 in the same window. Source depth averages 3 original sources per story, versus 4.1 across the same-window beat baseline. Office of Prescription Drug Promotion (OPDP) appears in 1 tracked Healthcare story from March 9, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 30 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Office of Prescription Drug Promotion (OPDP). Shared-story counts are live from our verified record — not editorial picks.
A renewed public debate over Direct-to-Consumer Advertising (DTCA) is challenging the pharmaceutical industry's marketing status quo in the United States. As healthcare costs escalate, regulators and lawmakers are weighing the educational benefits of patient outreach against the risks of over-prescription and inflated drug prices.
Office of Prescription Drug Promotion (OPDP) is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
